186 related articles for article (PubMed ID: 12079737)
21. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
Santos M; Marcos R; Assunção M; Matos AJ
Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
[TBL] [Abstract][Full Text] [Related]
22. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
[TBL] [Abstract][Full Text] [Related]
24. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
[TBL] [Abstract][Full Text] [Related]
25. Value of Western blotting in the clinical follow-up of canine leishmaniasis.
Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM
J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690
[TBL] [Abstract][Full Text] [Related]
26. Treatment of canine Old World visceral leishmaniasis: a systematic review.
Noli C; Auxilia ST
Vet Dermatol; 2005 Aug; 16(4):213-32. PubMed ID: 16101793
[TBL] [Abstract][Full Text] [Related]
27. Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino.
Neogy AB; Vouldoukis I; da Costa JM; Monjour L
Vet Parasitol; 1994 Sep; 54(4):367-73. PubMed ID: 7839561
[TBL] [Abstract][Full Text] [Related]
28. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
Rougier S; Vouldoukis I; Fournel S; Pérès S; Woehrlé F
Vet Parasitol; 2008 May; 153(3-4):244-54. PubMed ID: 18337012
[TBL] [Abstract][Full Text] [Related]
31. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
Gramiccia M; Gradoni L; Orsini S
Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
[TBL] [Abstract][Full Text] [Related]
32. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin.
Pennisi MG; De Majo M; Masucci M; Britti D; Vitale F; Del Maso R
Vet Rec; 2005 Mar; 156(11):346-9. PubMed ID: 15789648
[TBL] [Abstract][Full Text] [Related]
34. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
[TBL] [Abstract][Full Text] [Related]
35. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
36. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
37. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
[TBL] [Abstract][Full Text] [Related]
38. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
[TBL] [Abstract][Full Text] [Related]
39. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
40. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]